Reuters logo
BRIEF-Cadila Healthcare says ‍Zydus gets USFDA approval for minocycline hydrochloride extended-release tablets​
November 24, 2017 / 4:26 AM / 20 days ago

BRIEF-Cadila Healthcare says ‍Zydus gets USFDA approval for minocycline hydrochloride extended-release tablets​

Nov 24 (Reuters) - Cadila Healthcare Ltd

* Says ‍Zydus receives approval from USFDA for minocycline hydrochloride extended - release tablets

* Product to be manufactured at formulations manufacturing facilty at Moraiya, Ahmedabad‍​​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below